The Telegraph: Stem cell therapies and the future of healthcare
BLOG | WideCells Group
WideCells Group Plc is a strong advocate of regenerative medicine and firmly believes that stem cells have the potential to revolutionise our future medical landscape. The Company is therefore delighted to announce its participation in Business Reporter's “Future of Healthcare” feature, which is hosted by the Daily Telegraph Online.
In the interview with Business Reporter, WideCells Group CEO João Andrade shares his views on how cord blood and stem cell technologies are set to transform global healthcare. He also outlines how WideCells Group is driving development within the industry through its three complementary divisions, which aim to make stem cell treatment accessible and affordable globally.
To see the full interview with Business Reporter please cick here